Poly(ADP-ribose) Polymerase-1 (PARP-1) Contributes to the Barrier Function of a Vertebrate Chromatin Insulator

被引:10
|
作者
Aker, Mari [1 ]
Bomsztyk, Karol [2 ]
Emery, David W. [1 ,2 ,3 ]
机构
[1] Univ Washington, Div Med Genet, Seattle, WA 98195 USA
[2] Univ Washington, UW Med Lake Union, Dept Med, Seattle, WA 98195 USA
[3] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
BETA-GLOBIN INSULATOR; ENHANCER BLOCKING; DNA-BINDING; CTCF; TRANSCRIPTION; PROTEINS; VECTORS;
D O I
10.1074/jbc.M110.174532
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The prototypic chromatin insulator cHS4 has proven effective in reducing silencing chromosomal position effects in a variety of settings. Most of this barrier insulator activity has been mapped to a 250-bp core region, as well as to several proteins that bind this region. However, recent studies from our laboratory demonstrated that an extended 400-bp core region of the cHS4 element is necessary to achieve full barrier insulator activity when used as a single copy in the context of recombinant gammaretroviral and lentiviral vectors. In this study, electrophoretic gel mobility shift assays revealed specific DNA-protein binding activities associated with the distal portion of this extended core region. Affinity purification and tandem mass spectrometry studies led to the identification of one of these proteins as poly(ADP-ribose) polymerase-1 (PARP-1). The identity of this binding activity as PARP-1 was subsequently verified by a variety of biochemical studies in vitro and by chromatin immunoprecipitation studies in vivo. Functional studies with gammaretroviral reporter vectors in cell lines and primary mouse bone marrow progenitor cultures showed that cHS4 barrier activity was abrogated upon mutation of the putative PARP1-binding site or upon treatment with a PARP inhibitor, respectively. The barrier activity of the cHS4 element was also found to be abrogated in studies using bone marrow from Parp1-null mice. Taken together, this study demonstrates that binding of PARP-1 plays a key functional role in the barrier activity of the extended cHS4 insulator core element.
引用
收藏
页码:37589 / 37597
页数:9
相关论文
共 50 条
  • [1] PARP-1 Contributes to the Barrier Function of a Vertebrate Chromatin Insulator
    Emery, David W.
    Bomsztyk, Karol
    Aker, Mari
    MOLECULAR THERAPY, 2009, 17 : S162 - S162
  • [2] POLY (ADP-RIBOSE) POLYMERASE-1 (PARP-1) INDUCES TROPHOBLAST SYNCYTIALIZATION
    Pater, Justin
    Shah, Girish
    MacPhee, Daniel
    PLACENTA, 2013, 34 (09) : A16 - A16
  • [3] Docking and scoring inhibitors of Poly(ADP-ribose) Polymerase-1 (PARP-1).
    Kumpf, RA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U409 - U409
  • [4] Poly (ADP-RIBOSE) Polymerase-1 (PARP-1) modulates astrocyte activation
    Phulwani, NK
    Kielian, T
    JOURNAL OF NEUROCHEMISTRY, 2006, 96 : 44 - 44
  • [5] Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors in cancer chemotherapy
    Cepeda, Victoria
    Fuertes, Miguel A.
    Castilla, Josefina
    Alonso, Carlos
    Quevedo, Celia
    Soto, Manual
    Perez, Jose M.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2006, 1 (01) : 39 - 53
  • [6] Poly(ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications
    Sodhi, Rupinder K.
    Singh, Nirmal
    Jaggi, Amteshwar S.
    VASCULAR PHARMACOLOGY, 2010, 53 (3-4) : 77 - 87
  • [7] Signaling Mechanism of Poly(ADP-Ribose) Polymerase-1 (PARP-1) in Inflammatory Diseases
    Ba, Xueqing
    Garg, Nisha Jain
    AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (03): : 946 - 955
  • [8] PARP-1 (Poly[ADP-Ribose] Polymerase-1): A Novel Target in Aortic Aneurysm
    Alves-Lopes, Rheure
    Touyz, Rhian M.
    HYPERTENSION, 2018, 72 (05) : 1087 - 1089
  • [9] Inhibition of poly (ADP-ribose) Polymerase-1 (PARP-1) improves endothelial function in pulmonary hypertension
    Shafiq, Mohammad
    Lone, Zahid Rasool
    Abdulkareem, Adam Olaitan
    Kaur, Gurpreet
    Navya, Sai
    Singh, Himalaya
    Jagavelu, Kumaravelu
    Hanif, Kashif
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 80
  • [10] Substituted uracil derivatives as potent inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)
    Steinhagen, H
    Gerisch, M
    Mittendorf, J
    Schlemmer, KH
    Albrecht, B
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (21) : 3187 - 3190